Overview
Portfolio
More
アグリビジネス投資育成株式会社
We invest in agricultural, forestry, and fishery corporations as well as companies that support the food value chain in Japan. Our goal is to strengthen equity capital and provide management support to promote sustainabl...
Portfolio
4+
Employees
N/A
Founded
N/A
AUM
≈ $0.0
Investment focus
Stages
No stages listed
Industries
Agriculture Technology
Geographic scope
Japan
アグリビジネス投資育成株式会社
We invest in agricultural, forestry, and fishery corporations as well as companies that support the food value chain in Japan. Our goal is to strengthen equity capital and provide management support to promote sustainable food production and regional development across the country.
Portfolio
4+
Employees
N/A
Founded
N/A
AUM
≈ $0.0
Showing 3 of 3 matched portfolio companies
Every provides a suite of video‑media platforms that offer daily, expert‑curated cooking videos, parenting guidance, and digital retail solutions. Through its DELISH KITCHEN, MAMADAYS, and Retail HUB services, users can access step‑by‑step recipes, pregnancy and child‑development resources, and integrated in‑store and online shopping tools, all personalized via data‑driven analytics.
Funding: $116.7M
Rough estimate of the amount of funding raised
Funding: $116.7M
Rough estimate of the amount of funding raised
Yango develops and deploys a diverse ecosystem of digital services, including mobility, delivery, and entertainment, tailored for regional markets. This technology platform adapts global innovations to meet specific local consumer and business needs across multiple continents. The company focuses on integrating services like ride-hailing, food delivery, and digital payments into a cohesive user experience.
Physios Biotech develops microphysiological systems (MPS) that replicate human organ functions and rare disease environments, utilizing advanced nanotechnology for high human extrapolation. Their technology reduces reliance on animal testing and accelerates drug development timelines by providing accurate safety evaluations and therapeutic assessments for rare cancers.
Showing 1 of 1 unmatched portfolio company